ABL Bio Inc. (298380.KQ)

KRW 27400.0

(-5.03%)

Long Term Debt Summary of ABL Bio Inc.

  • ABL Bio Inc.'s latest annual long term debt in 2023 was 43 Billion KRW , up 7.5% from previous year.
  • ABL Bio Inc.'s latest quarterly long term debt in 2024 Q2 was 43 Billion KRW , down 0.0% from previous quarter.
  • ABL Bio Inc. reported annual long term debt of 40 Billion KRW in 2022, up 55212.03% from previous year.
  • ABL Bio Inc. reported annual long term debt of 72.31 Million KRW in 2021, down -86.98% from previous year.
  • ABL Bio Inc. reported quarterly long term debt of 43 Billion KRW for 2024 Q2, down 0.0% from previous quarter.
  • ABL Bio Inc. reported quarterly long term debt of 409.91 Million KRW for 2023 Q1, down -98.98% from previous quarter.

Annual Long Term Debt Chart of ABL Bio Inc. (2023 - 2016)

Historical Annual Long Term Debt of ABL Bio Inc. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 43 Billion KRW 7.5%
2022 40 Billion KRW 55212.03%
2021 72.31 Million KRW -86.98%
2020 555.33 Million KRW 0.0%
2019 - KRW 0.0%
2018 - KRW -100.0%
2017 7.62 Billion KRW 227.76%
2016 2.32 Billion KRW 0.0%

Peer Long Term Debt Comparison of ABL Bio Inc.

Name Long Term Debt Long Term Debt Difference
Sam Chun Dang Pharm. Co., Ltd 16 Billion KRW -168.75%
Hyundai Bioscience Co., Ltd. 32.43 Million KRW -132485.101%
ST Pharm Co.,Ltd. 159.68 Billion KRW 73.073%
Cellid, Co., Ltd. 6.48 Billion KRW -562.841%